Singapore markets closed
Straits Times Index
3,348.87 +12.28 (+0.37%) S&P 500
5,277.51 +42.03 (+0.80%) Dow
38,686.32 +574.82 (+1.51%) Nasdaq
16,735.02 -2.08 (-0.01%) Bitcoin USD
69,087.91 +875.68 (+1.28%) CMC Crypto 200
1,487.38 +19.45 (+1.32%)
Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)
NSE - NSE Real-time price. Currency in INR
Add to watchlist
At close: 03:30PM IST
Currency in INR
Valuation measures4
| Market cap (intra-day) | 3.50T |
| Enterprise value | 3.34T |
| Trailing P/E | 36.59 |
| Forward P/E | 26.67 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 7.34 |
| Price/book (mrq) | 5.50 |
| Enterprise value/revenue | 6.98 |
| Enterprise value/EBITDA | 24.02 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.53 |
| 52-week change 3 | 44.71% |
| S&P500 52-week change 3 | 23.49% |
| 52-week high 3 | 1,638.85 |
| 52-week low 3 | 977.30 |
| 50-day moving average 3 | 1,538.56 |
| 200-day moving average 3 | 1,352.15 |
Share statistics
| Avg vol (3-month) 3 | 2.84M |
| Avg vol (10-day) 3 | 4.47M |
| Shares outstanding 5 | 2.4B |
| Implied shares outstanding 6 | 2.43B |
| Float 8 | 1.06B |
| % held by insiders 1 | 54.69% |
| % held by institutions 1 | 27.10% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 12.5 |
| Forward annual dividend yield 4 | 0.86% |
| Trailing annual dividend rate 3 | 13.50 |
| Trailing annual dividend yield 3 | 0.92% |
| 5-year average dividend yield 4 | 0.94 |
| Payout ratio 4 | 31.33% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 09 Feb 2024 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 29 Jul 2013 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Mar 2024 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 19.75% |
| Operating margin (ttm) | 20.37% |
Management effectiveness
| Return on assets (ttm) | 7.84% |
| Return on equity (ttm) | 15.20% |
Income statement
| Revenue (ttm) | 484.97B |
| Revenue per share (ttm) | 202.06 |
| Quarterly revenue growth (yoy) | 9.60% |
| Gross profit (ttm) | N/A |
| EBITDA | 129.87B |
| Net income avi to common (ttm) | 95.76B |
| Diluted EPS (ttm) | 39.85 |
| Quarterly earnings growth (yoy) | 33.80% |
Balance sheet
| Total cash (mrq) | 191.05B |
| Total cash per share (mrq) | 79.89 |
| Total debt (mrq) | 32.74B |
| Total debt/equity (mrq) | 4.88% |
| Current ratio (mrq) | 2.56 |
| Book value per share (mrq) | 266.22 |
Cash flow statement
| Operating cash flow (ttm) | 121.35B |
| Levered free cash flow (ttm) | 75.42B |
© 2024 Yahoo. All rights reserved.